Results 31 to 40 of about 3,808,290 (359)
Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia. [PDF]
, 2019 Dasatinib, a second-generation BCR-ABL1 tyrosine kinase inhibitor, is approved for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia, both as first-line therapy and after imatinib intolerance or ...Abruzzese, Elisabetta, Cortes, Jorge E, Hochhaus, Andreas, Hughes, Timothy P, Laneuville, Pierre, Lipton, Jeffrey H, Paar, David, Rea, Delphine, Rousselot, Philippe, Shah, Neil P, Snyder, David S +10 morecore +2 more sourcesRoad traffic pollution and childhood leukemia: a nationwide case-control study in Italy [PDF]
, 2016 Background The association of childhood leukemia with traffic pollution was considered in a number of studies from 1989 onwards, with results not entirely consistent and little information regarding subtypes.Alberto Salvan, Alessandra Benvenuti, Alessandra Greco Veneto, Alessandra Ranucci, Alessandra Ranucci, Alessandro Polichetti, Alessandro Pulsoni, Andrea Farioli, Andrea Pession, Carmelo Rizzari, Chiara Badaloni, Claudia Galassi, Corrado Magnani, Corrado Magnani, Cristina Nuccetelli, Daniela Ferrante, Daniela Ferrante, Daniele Monetti, Domenico Franco Merlo, Domenico Franco Merlo, Egidio Celentano, Egidio Celentano, Erni Guarino, Francesco Bochicchio, Francesco Forastiere, Francesco Forastiere, Franco Locatelli, Franco Pannelli, Gabriella Bernini, Gian Luca DeSalvo, Gigliola de Nichilo, Gino Schilirò, Giorgio Assennato, Giorgio Assennato, Giulia Cesaroni, Giuseppe Masera, Giuseppe Sampietro, Lia Lidia Luzzatto, Liliana Minelli, Liliana Minelli, Lorenzo Gafà, Lucia Miligi, Lucia Miligi, Luigi Bisanti, Luigi Bisanti, Manuela Chiavarini, Maria Valeria Torregrossa, Maria Valeria Torregrossa, Marina Cuttini, Marina Cuttini, Maurizio Aricò, Paola Michelozzi, Paola Michelozzi, Paola Mosciatti, Paola Mosciatti, Paola Zambon, Paola Zambon, Pia Massaglia, Pierfranco Biddau, Pierluigi Cocco, Pierluigi Cocco, Riccardo Haupt, Riccardo Haupt, Roberto Rondelli, Roberto Rondelli, Roberto Targhetta, Rosaria Maria Valenti, Santina Cannizzaro, Santina Cannizzaro, Serena Risica, Stefania Varotto, Stefano Mattioli, Stefano Mattioli, Stefano Parodi, Susanna Lagorio, Susanna Lagorio, Ursula Kirchmayer, Veronica Casotto, Vincenzo Poggi, Vittorio Bocchini +79 morecore +1 more sourceSimilar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Journal of Hematology & Oncology, 2023 There are situations where non-first-degree (NFD) related donors have to be considered as alternatives to first-degree (FD) related donors for haploidentical hematopoietic cell transplantation (HAPLO).Yishan Ye, Myriam Labopin, Jia Chen, Zafer Gulbas, Xi Zhang, Yener Koc, Didier Blaise, Fabio Ciceri, Emmanuelle Polge, Mohamed Houhou, Lin Li, Yi Luo, Depei Wu, He Huang, Mohamad Mohty, Norbert-Claude Gorin +15 moredoaj +1 more sourceA thoracic-epidural granulocytic sarcoma case that was diagnosed preceding the onset of and that recurred co-incidental to acute promyelocytic leukemia, which developed after surgical treatment. [PDF]
, 2004 Granulocytic sarcoma or chloroma is a tumor seen in myelocytic leukemia. Spinal epidural onset is rare and is generally seen before or together with the onset of myelocytic leukemia.Bayraktaroglu, Taner, Borazan, Ali, Demircan, Nejat, Ozdemir, Huseyin, Ozer, Tulay, Savranlar, Ahmet, Ustundag, Yucel +6 morecore +1 more sourceGenomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia
Haematologica, 2023
Pediatric acute myeloid leukemia (AML) is a highly heterogeneous disease making standardized measurable residual disease (MRD) assessment challenging. Currently, patient-specific DNA-based assays are only rarely applied for MRD assessment in pediatric ...Margarita Maurer-Granofszky, Stefan Kohrer, Susanna Fischer, Angela Schumich, Karin Nebral, Patrizia Larghero, Claus Meyer, Astrid Mecklenbrauker, Nora Muhlegger, Rolf Marschalek, Oskar A. Haas, Renate Panzer-Grumayer, Michael N. Dworzak +12 moredoaj +1 more sourceAllogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT
Haematologica, 2020 Deletion 5q or monosomy 5 (-5/5q-) in acute myeloid leukemia (AML) is a common high-risk feature that is referred to allogeneic stem cell transplantation.Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Edouard Forcade, Arnold Ganser, Liisa Volin, Mauricette Michallet, Didier Blaise, Ibrahim Yakoub-Agha, Johan Maertens, Carlos Richard Espiga, Jan Cornelissen, Jürgen Finke, Mohamad Mohty, Jordi Esteve, Arnon Nagler +15 moredoaj +1 more sourceAntitumor activity of an anti-CD98 antibody. [PDF]
, 2015 CD98 is expressed on several tissue types and specifically upregulated on fast-cycling cells undergoing clonal expansion. Various solid (e.g., nonsmall cell lung carcinoma) as well as hematological malignancies (e.g., acute myeloid leukemia) overexpress ...Cairns, Belinda, Cantor, Joseph M, Chinn, Lawrence, Duey, Dana, Ginsberg, Mark H, H van der Horst, Edward, Hayes, Gregory M, Levashova, Zoia, Lippincott, John, Tran, Hoang, Velilla, Timothy, Zachwieja, Joseph +11 morecore +1 more sourceAllogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Journal of Hematology & Oncology, 2017 Background Acute myeloid leukaemia (AML) with 17p abnormalities (abn(17p)) carries a very poor prognosis due to high refractoriness to conventional chemotherapy, and allogeneic stem cell transplantation (allo-SCT) appears as the only potential curative ...Xavier Poiré, Myriam Labopin, Johan Maertens, Ibrahim Yakoub-Agha, Didier Blaise, Norbert Ifrah, Gérard Socié, Tobias Gedde-Dhal, Nicolaas Schaap, Jan J. Cornelissen, Stéphane Vigouroux, Jaime Sanz, Lucienne Michaux, Jordi Esteve, Mohamad Mohty, Arnon Nagler +15 moredoaj +1 more sourceClinical and molecular characterization of early T-cell precursor leukemia : a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations [PDF]
, 2012 A subgroup of pediatric acute T-lymphoblastic leukemia (T-ALL) was characterized by a gene expression profile comparable to that of early T-cell precursors (ETPs) with a highly unfavorable outcome.Neumann, Martin, Heesch, Sandra, Gökbuget, Nicola, Schwartz, Stefan, Schlee, Cornelia, Benlasfer, Ouidad, Farhadi-Sartangi, Nasrin, Thibaut, Julia, Burmeister, Thomas, Hoelzer, Dieter, Hofmann, Wolf-Karsten, Thiel, Eckhard, Baldus, Claudia +12 morecore +1 more sourceAcute Promyelocytic Leukemia [PDF]
Cancers, 2020 Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML) cytogenetically characterized by a balanced reciprocal translocation between chromosomes 15 and 17, which results in the fusion between the promyelocytic leukemia (PML) gene and retinoic acid receptor-α (RARα) [...]Xavier Thomas, Maël Heibligopenaire +2 more sources
